VAXIMM || Startseite
Developing Active Anti-angiogenic Immunotherapies for Cancer Patients. VAXIMM is a privately held, Swiss-based vaccine company that is primarily focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Our initial produ